NuGen Medical Devices Inc. announce it has entered into a distribution agreement for its needle-free InsuJetTM medical device and consumables with Sol-Millennium Medical Inc. for a term of five years which NuGen estimates the value at approximately $204 million dollars with estimated gross margins of 72%. Sol-M is now the preferred distributor of InsuJetTM in Canada, Brazil, France and Spain where Sol-M has an extensive existing business footprint in the safety syringe and the diabetic supply business and where InsuJetTM is approved for sale as a medical device. Sol-M will be required to fulfill minimum yearly purchases to maintain its five-year distribution rights which NuGen estimates to be approximately $132 million dollars.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.15 CAD | +3.45% |
|
+57.89% | +25.00% |
1st Jan change | Capi. | |
---|---|---|
+25.00% | 23.82M | |
-5.50% | 181B | |
-5.79% | 99.52B | |
-6.59% | 65.82B | |
-8.38% | 45.21B | |
+8.42% | 43.85B | |
+10.10% | 42.17B | |
+10.97% | 28.75B | |
+18.89% | 25.39B | |
-8.39% | 23.5B |
- Stock Market
- Equities
- NGMD Stock
- News NuGen Medical Devices Inc.
- NuGen Medical Devices Inc. Enters into Distribution Agreement with Sol-Millennium Medical Inc